A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 15 350 KRW -5.6% Market Closed
Market Cap: 344.4B KRW
Have any thoughts about
AprilBio Co Ltd?
Write Note
AprilBio Co Ltd
/
Cash Flow Statement
/
Capital Expenditures

AprilBio Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AprilBio Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
A
AprilBio Co Ltd
KOSDAQ:397030
Capital Expenditures
-₩512m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Capital Expenditures
-₩350.4B
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
SK Bioscience Co Ltd
KRX:302440
Capital Expenditures
-₩50.3B
CAGR 3-Years
-70%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Capital Expenditures
-₩29.4B
CAGR 3-Years
19%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Capital Expenditures
-₩27.5B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Capital Expenditures
-₩33.4B
CAGR 3-Years
-35%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
No Stocks Found

AprilBio Co Ltd
Glance View

Market Cap
333.9B KRW
Industry
Biotechnology

AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Intrinsic Value
16 435.49 KRW
Undervaluation 7%
Intrinsic Value
Price
A
What is Intrinsic Value?

See Also

What is AprilBio Co Ltd's Capital Expenditures?
Capital Expenditures
-512m KRW

Based on the financial report for Dec 31, 2023, AprilBio Co Ltd's Capital Expenditures amounts to -512m KRW.

What is AprilBio Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-2%

Over the last year, the Capital Expenditures growth was -471%. The average annual Capital Expenditures growth rates for AprilBio Co Ltd have been -2% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.